Joe Shulman

Salesforce Route 53 MailJet SendInBlue Outlook Microsoft Office 365 Sophos Adobe Marketing Cloud Data Analytics Remote Basis

genetics obesity peptides metabolism rare disease biotechnology pharmaceuticals research health medicine clinical trials endocrinology orphan disease science advocacy epidemiology orphan drugs metabolic life sciences biotechnology: pharmaceutical preparations health care biotechnology research rhythm pharmaceuticals rare diseases mc4r pathway imcivree setmelanotide fda-approved bardet-biedl syndrome hyperphagia obesity medication precision medicine pediatric obesity genetic testing leptin receptor deficiency pomc deficiency pcsk1 deficiency rare neuroendocrine diseases hunger management medical support programs dietary treatment hormonal regulation investigational drugs drug development biopharmaceutical patient education clinical focus healthcare providers research & development healthcare access rare genetic disorders metabolic diseases therapeutic innovation patient care medical communications patient advocacy market authorization disease understanding healthcare collaboration long-term weight management symptom relief medical compliance scientific publications therapeutic strategies community engagement chronic disease management neurological health appetite control obesity management neuroendocrine disorders melanocortin-4 receptor severe obesity genetic disorders targeted therapies chronic weight management patient-centric care innovative treatments global reach community-focused patient outcomes orphan drug designation therapeutic focus pipeline development acquired hypothalamic obesity congenital hyperinsulinism healthcare support stigma-free care scientific innovation collaboration commercial-stage company medical health wellness & fitness hospital & health care